Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2837-2842
© 1997 American Heart Association, Inc.
Articles |
Common C-to-T Substitution at Position -480 of the Hepatic Lipase Promoter Associated With a Lowered Lipase Activity in Coronary Artery Disease Patients
From the Departments of Internal Medicine III (H.J., L.W., J.C.B.), Biochemistry (H.J., A.J.M.V.), and Clinical Genetics (D.J.J.H., A. van den O.), Erasmus University Rotterdam; the Department of Molecular Medicine, Academic Medical Center, University of Amsterdam (J.J.P.K.); the Department of Cardiology, University of Leiden (J.W.J.); and the Department of Chronic Diseases and Environmental Epidemiology, National Institute of Public Health and Environmental Protection, Bilthoven (J.C.S.), The Netherlands.
Correspondence to Hans Jansen, PhD, Department of Internal Medicine III, BD 277, Erasmus University Rotterdam, Dr Molewaterplein 50, 3015 GD Rotterdam, POB 1738, 3000 DR Rotterdam, The Netherlands. E-mail jansen{at}bc1.fgg.eur.nl
Abstract We studied the molecular basis of low hepatic lipase (HL) activity in normolipidemic male patients with angiographically documented coronary artery disease (CAD). In 18 subjects with a lowered HL activity (<225 mU/mL), all nine exons of the HL gene and part of the promoter region (nucleotides -524 to +7) were sequenced. No structural mutations in the coding part of the HL gene were found, but 50% of the subjects showed a C-to-T substitution at nucleotide -480. Screening for the base substitution in 782 patients yielded an allele frequency of 0.213 (297 heterozygotes, 18 homozygotes). In a group of 316 nonsymptomatic control subjects, the allele frequency was 0.189, which is significantly less than in the CAD patients (P=.035). In the CAD patients, the C-to-T substitution was associated with a lowered lipase activity (heterozygotes -15%, homozygotes -20%). The patients were divided into quartiles on the basis of HL activity. Sixty percent (allele frequency 0.32) of the patients in the lowest quartile (HL activity <306 mU/mL) had the gene variant against 27% (allele frequency 0.14) in the highest quartile (HL activity >466 mU/mL). In the noncarriers, but not in the carriers, HL activity was related with plasma insulin, being increased at higher insulin concentration. Homozygous carriers had a significantly higher HDL cholesterol level than noncarriers (1.13±0.28 mmol/L versus 0.92±0.22 mmol/L, P<.02). Our results show that a C-to-T substitution at -480 of the HL promoter is associated with a lowered HL activity. The base substitution, or a closely linked gene variation, may contribute to the variation in HL activity and affect plasma lipoprotein metabolism.
Key Words: hepatic lipase • promoter • polymorphism • deficiency • coronary artery disease
This article has been cited by other articles:
 |
|
 |
|
  S. Imamura, J. Kobayashi, S. Sakasegawa, A. Nohara, K. Nakajima, M. Kawashiri, A. Inazu, M. Yamagishi, J. Koizumi, and H. Mabuchi A novel method for measuring human hepatic lipase activity in postheparin plasma J. Lipid Res., February 1, 2007; 48(2): 453 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Orchard, T. Costacou, A. Kretowski, and R. W. Nesto Type 1 diabetes and coronary artery disease. Diabetes Care, November 1, 2006; 29(11): 2528 - 2538. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ohashi, H. Mu, X. Wang, Q. Yao, and C. Chen Reverse cholesterol transport and cholesterol efflux in atherosclerosis QJM, December 1, 2005; 98(12): 845 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K P Burdon, C D Langefeld, S R Beck, L E Wagenknecht, J J Carr, B I Freedman, D Herrington, and D W Bowden Association of genes of lipid metabolism with measures of subclinical cardiovascular disease in the Diabetes Heart Study J. Med. Genet., September 1, 2005; 42(9): 720 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Stefan, S. Schafer, F. Machicao, J. Machann, F. Schick, C. D. Claussen, M. Stumvoll, H.-U. Haring, and A. Fritsche Liver Fat and Insulin Resistance Are Independently Associated with the -514C>T Polymorphism of the Hepatic Lipase Gene J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4238 - 4243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zhang, R. Lopez-Ridaura, E. B Rimm, N. Rifai, D. J Hunter, and F. B Hu Interactions between the -514C->T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations among US diabetic men Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1429 - 1435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-M. Fan, P. Dastidar, H. Jokela, R. Punnonen, and T. Lehtimaki Hepatic Lipase C-480T Genotype-Dependent Benefit from Long-Term Hormone Replacement Therapy for Atherosclerosis Progression in Postmenopausal Women J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3786 - 3792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Gomez, F. Perez-Jimenez, C. Marin, J. A. Moreno, M. J. Gomez, C. Bellido, P. Perez-Martinez, F. Fuentes, J. A. Paniagua, and J. Lopez-Miranda The -514 C/T polymorphism in the hepatic lipase gene promoter is associated with insulin sensitivity in a healthy young population J. Mol. Endocrinol., April 1, 2005; 34(2): 331 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Bos, J. M Dekker, E. J. Feskens, M. C Ocke, G. Nijpels, C. D. Stehouwer, L. M Bouter, R. J Heine, and H. Jansen Interactions of dietary fat intake and the hepatic lipase -480C->T polymorphism in determining hepatic lipase activity: the Hoorn Study Am. J. Clinical Nutrition, April 1, 2005; 81(4): 911 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Santamarina-Fojo, H. Gonzalez-Navarro, L. Freeman, E. Wagner, and Z. Nong Hepatic Lipase, Lipoprotein Metabolism, and Atherogenesis Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1750 - 1754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Isaacs, F. A. Sayed-Tabatabaei, O. T. Njajou, J. C. M. Witteman, and C. M. van Duijn The -514 C->T Hepatic Lipase Promoter Region Polymorphism and Plasma Lipids: A Meta-Analysis J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3858 - 3863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Shuldiner, N. Hoppman, and T. I. Pollin Hepatic Lipase Genotype, Diabetes Risk, and Implications for Preventative Medicine J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2015 - 2018. [Full Text] [PDF]
|
|
|
|
|
|
M. C. Carr, J. D. Brunzell, and S. S. Deeb Ethnic differences in hepatic lipase and HDL in Japanese, black, and white Americans: role of central obesity and LIPC polymorphisms J. Lipid Res., March 1, 2004; 45(3): 466 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y M Fan, J T Salonen, T A Koivu, T-P Tuomainen, K Nyyssonen, T A Lakka, R Salonen, K Seppanen, S T Nikkari, E Tahvanainen, et al. Hepatic lipase C-480T polymorphism modifies the effect of HDL cholesterol on the risk of acute myocardial infarction in men: a prospective population based study J. Med. Genet., March 1, 2004; 41(3): e28 - 28. [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Hokanson, M. I. Kamboh, S. Scarboro, R. H. Eckel, and R. F. Hamman Effects of the Hepatic Lipase Gene and Physical Activity on Coronary Heart Disease Risk Am. J. Epidemiol., November 1, 2003; 158(9): 836 - 843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E S. Tai, D. Corella, M. Deurenberg-Yap, J. Cutter, S. K. Chew, C. E. Tan, and J. M. Ordovas Dietary Fat Interacts with the -514C>T Polymorphism in the Hepatic Lipase Gene Promoter on Plasma Lipid Profiles in a Multiethnic Asian Population: The 1998 Singapore National Health Survey J. Nutr., November 1, 2003; 133(11): 3399 - 3408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Soro, M. Jauhiainen, C. Ehnholm, and M.-R. Taskinen Determinants of low HDL levels in familial combined hyperlipidemia J. Lipid Res., August 1, 2003; 44(8): 1536 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Deeb, A. Zambon, M. C. Carr, A. F. Ayyobi, and J. D. Brunzell Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet J. Lipid Res., July 1, 2003; 44(7): 1279 - 1286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. V. Andersen, H. H. Wittrup, A. Tybjaerg-Hansen, R. Steffensen, P. Schnohr, and B.o. G. Nordestgaard Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: The Copenhagen City Heart Study J. Am. Coll. Cardiol., June 4, 2003; 41(11): 1972 - 1982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Anderson and J. F. Carlquist Genetic polymorphisms of hepatic lipase and cholesteryl ester transfer protein, intermediate phenotypes, and coronary risk: Do they add up yet? J. Am. Coll. Cardiol., June 4, 2003; 41(11): 1990 - 1993. [Full Text] [PDF]
|
|
|
|
|
|
M. Brundert, J. Heeren, H. Greten, and F. Rinninger Hepatic lipase mediates an increase in selective uptake of HDL-associated cholesteryl esters by cells in culture independent from SR-BI J. Lipid Res., May 1, 2003; 44(5): 1020 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. I.L. Berk-Planken, N. Hoogerbrugge, R. P. Stolk, A. H. Bootsma, and H. Jansen Atorvastatin Dose-Dependently Decreases Hepatic Lipase Activity in Type 2 Diabetes: Effect of sex and the LIPC promoter variant Diabetes Care, February 1, 2003; 26(2): 427 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Ordovas, D. Corella, S. Demissie, L. A. Cupples, P. Couture, O. Coltell, P. W.F. Wilson, E. J. Schaefer, and K. L. Tucker Dietary Fat Intake Determines the Effect of a Common Polymorphism in the Hepatic Lipase Gene Promoter on High-Density Lipoprotein Metabolism: Evidence of a Strong Dose Effect in This Gene-Nutrient Interaction in the Framingham Study Circulation, October 29, 2002; 106(18): 2315 - 2321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Su, S. Zhang, D. W. Nebert, L. Zhang, D. Huang, Y. Hou, L. Liao, and C. Xiao A novel allele in the promoter of the hepatic lipase is associated with increased concentration of HDL-C and decreased promoter activity J. Lipid Res., October 1, 2002; 43(10): 1595 - 1601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Somekawa, H. Umeki, K. Kobayashi, S. Tomura, T. Aso, and H. Hamaguchi Effects of Hormone Replacement Therapy and Hepatic Lipase Polymorphism on Serum Lipid Profiles in Postmenopausal Japanese Women J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4766 - 4770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Jansen, A. J. M. Verhoeven, and E. J. G. Sijbrands Hepatic lipase: a pro- or anti-atherogenic protein? J. Lipid Res., September 1, 2002; 43(9): 1352 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Perret, L. Mabile, L. Martinez, F. Terce, R. Barbaras, and X. Collet Hepatic lipase: structure/function relationship, synthesis, and regulation J. Lipid Res., August 1, 2002; 43(8): 1163 - 1169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Gonzalez-Navarro, Z. Nong, L. Freeman, A. Bensadoun, K. Peterson, and S. Santamarina-Fojo Identification of mouse and human macrophages as a site of synthesis of hepatic lipase J. Lipid Res., May 1, 2002; 43(5): 671 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Rundek, M. S. Elkind, J. Pittman, B. Boden-Albala, S. Martin, S. E. Humphries, S.-H. H. Juo, and R. L. Sacco Carotid Intima-Media Thickness Is Associated With Allelic Variants of Stromelysin-1, Interleukin-6, and Hepatic Lipase Genes: The Northern Manhattan Prospective Cohort Study Stroke, May 1, 2002; 33(5): 1420 - 1423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Hokanson, S. Cheng, J. K. Snell-Bergeon, B. A. Fijal, M. A. Grow, C. Hung, H. A. Erlich, J. Ehrlich, R. H. Eckel, and M. Rewers A Common Promoter Polymorphism in the Hepatic Lipase Gene (LIPC-480C>T) Is Associated With an Increase in Coronary Calcification in Type 1 Diabetes Diabetes, April 1, 2002; 51(4): 1208 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.C. Carr, A.F. Ayyobi, S.J. Murdoch, S.S. Deeb, and J.D. Brunzell Contribution of Hepatic Lipase, Lipoprotein Lipase, and Cholesteryl Ester Transfer Protein to LDL and HDL Heterogeneity in Healthy Women Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 667 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Dugi, K. Brandauer, N. Schmidt, B. Nau, J. G. Schneider, S. Mentz, T. Keiper, J. R. Schaefer, C. Meissner, H. Kather, et al. Low Hepatic Lipase Activity Is a Novel Risk Factor for Coronary Artery Disease Circulation, December 18, 2001; 104(25): 3057 - 3062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Talmud, L. Berglund, E. M. Hawe, D. M. Waterworth, C. R. Isasi, R. E. Deckelbaum, T. Starc, H. N. Ginsberg, S. E. Humphries, and S. Shea Age-Related Effects of Genetic Variation on Lipid Levels: The Columbia University BioMarkers Study Pediatrics, September 1, 2001; 108(3): e50 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Carr, J. E. Hokanson, A. Zambon, S. S. Deeb, P. H. R. Barrett, J. Q. Purnell, and J. D. Brunzell The Contribution of Intraabdominal Fat to Gender Differences in Hepatic Lipase Activity and Low/High Density Lipoprotein Heterogeneity J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2831 - 2837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zambon, S. S. Deeb, B. G. Brown, J. E. Hokanson, and J. D. Brunzell Common Hepatic Lipase Gene Promoter Variant Determines Clinical Response to Intensive Lipid-Lowering Treatment Circulation, February 13, 2001; 103(6): 792 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-H. H. Juo, Z. Han, J. D. Smith, L. Colangelo, and K. Liu romoter polymorphisms of hepatic lipase gene influence HDL2 but not HDL3 in African American men: CARDIA study J. Lipid Res., February 1, 2001; 42(2): 258 - 264. [Abstract] [Full Text]
|
|
|
|
|
|
D. M. Waterworth, J. A. Hubacek, J. Pitha, J. Kovar, R. Poledne, S. E. Humphries, and P. J. Talmud Plasma levels of remnant particles are determined in part by variation in the APOC3 gene insulin response element and the APOCI;-APOE cluster J. Lipid Res., July 1, 2000; 41(7): 1103 - 1109. [Abstract] [Full Text]
|
|
|
|
|
|
J. Pihlajamaki, L. Karjalainen, P. Karhapaa, I. Vauhkonen, M.-R. Taskinen, S. S. Deeb, and M. Laakso G-250A Substitution in Promoter of Hepatic Lipase Gene Is Associated With Dyslipidemia and Insulin Resistance in Healthy Control Subjects and in Members of Families With Familial Combined Hyperlipidemia Arterioscler. Thromb. Vasc. Biol., July 1, 2000; 20(7): 1789 - 1795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. van 't Hooft, B. Lundahl, F. Ragogna, F. Karpe, G. Olivecrona, and A. Hamsten Functional Characterization of 4 Polymorphisms in Promoter Region of Hepatic Lipase Gene Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1335 - 1339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Couture, J. D. Otvos, L. A. Cupples, C. Lahoz, P. W. F. Wilson, E. J. Schaefer, and J. M. Ordovas Association of the C-514T Polymorphism in the Hepatic Lipase Gene With Variations in Lipoprotein Subclass Profiles : The Framingham Offspring Study Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 815 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Allayee, K. M. Dominguez, B. E. Aouizerat, R. M. Krauss, J. I. Rotter, J. Lu, R. M. Cantor, T. W. A. de Bruin, and A. J. Lusis Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia J. Lipid Res., February 1, 2000; 41(2): 245 - 252. [Abstract] [Full Text]
|
|
|
|
|
|
S. S. Deeb and R. Peng The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity J. Lipid Res., January 1, 2000; 41(1): 155 - 158. [Abstract] [Full Text]
|
|
|
|
|
|
M. C. Carr, J. E. Hokanson, S. S. Deeb, J. Q. Purnell, E. S. Mitchell, and J. D. Brunzell A Hepatic Lipase Gene Promoter Polymorphism Attenuates the Increase in Hepatic Lipase Activity With Increasing Intra-abdominal Fat in Women Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2701 - 2707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. G. Sijbrands, M. J. V. Hoffer, A. E. Meinders, L. M. Havekes, R. R. Frants, A. H. M. Smelt, and P. De Knijff Severe Hyperlipidemia in Apolipoprotein E2 Homozygotes Due to a Combined Effect of Hyperinsulinemia and an SstI Polymorphism Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2722 - 2729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. V. Shohet, G. L. Vega, A. Anwar, J. E. Cigarroa, S. M. Grundy, and J. C. Cohen Hepatic Lipase (LIPC) Promoter Polymorphism in Men With Coronary Artery Disease : Allele Frequency and Effects on Hepatic Lipase Activity and Plasma HDL-C Concentrations Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1975 - 1978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. De Oliveirae Silva, M. Kong, Z. Han, C. Starr, E. M. Kass, S.-H. H. Juo, D. Foster, H. M. Dansky, M. Merkel, K. Cundey, et al. Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females J. Lipid Res., July 1, 1999; 40(7): 1211 - 1221. [Abstract] [Full Text]
|
|
|
|
|
|
A. Zambon, J. E. Hokanson, B. G. Brown, and J. D. Brunzell Evidence for a New Pathophysiological Mechanism for Coronary Artery Disease Regression : Hepatic Lipase–Mediated Changes in LDL Density Circulation, April 20, 1999; 99(15): 1959 - 1964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.J. Ghadessy, S.L. Liow, and E.L. Yong Mutations in the promoter region of the androgen receptor gene are not common in males with idiopathic infertility Mol. Hum. Reprod., March 1, 1999; 5(3): 287 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Jansen, G. Chu, C. Ehnholm, J. Dallongeville, V. Nicaud, and P. J. Talmud The T Allele of the Hepatic Lipase Promoter Variant C-480T Is Associated With Increased Fasting Lipids and HDL and Increased Preprandial and Postprandial LpCIII:B : European Atherosclerosis Research Study (EARS) II Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 303 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zambon, S. S. Deeb, J. E. Hokanson, B. G. Brown, and J. D. Brunzell Common Variants in the Promoter of the Hepatic Lipase Gene Are Associated With Lower Levels of Hepatic Lipase Activity, Buoyant LDL, and Higher HDL2 Cholesterol Arterioscler. Thromb. Vasc. Biol., November 1, 1998; 18(11): 1723 - 1729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.C. Carr, A.F. Ayyobi, S.J. Murdoch, S.S. Deeb, and J.D. Brunzell Contribution of Hepatic Lipase, Lipoprotein Lipase, and Cholesteryl Ester Transfer Protein to LDL and HDL Heterogeneity in Healthy Women Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 667 - 673. [Abstract] [Full Text] [PDF]
|
|